11:26 PM EDT, 10/05/2026 (MT Newswires) -- AstraZeneca (AZN.L, AZN.ST) unveiled a strategic research and development center in Massachusetts, US, as part of its planned investment of over $1 billion in the state. The 570,000-square-foot, 18-story facility will house nearly 2,000 researchers and scientists to accelerate the biopharmaceutical company's oncology, cell therapy, chronic disease, and rare disease pipeline, according to a Monday release. Overall, AstraZeneca has committed to invest $50 billion in the US.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.